Contact Next Edge Capital
1 Toronto Street, Suite 200
Toronto, ON M5C 2V6
The Next Edge Biotech and Life Sciences Opportunities Fund (the ‘Fund’) seeks short and long-term capital appreciation through the ownership of biotechnology and life sciences companies. Investments by the Fund may be made globally.
A unique, well-defined process of investing in biotechnology and life sciences companies.
Eden Rahim is the Portfolio Manager for the Next Edge Biotech and Life Sciences Opportunities Fund. Eden’s broad experience includes over twenty-five years as a Portfolio and Hedge Fund Money Manager, Options Strategist, Derivatives & Biotech Analyst.
Eden possesses a top quartile 5-year 5-Star growth fund Portfolio Manager track record on over $1 billion in assets across 4 mandates at RBC Global Asset Management, in addition, Eden has delivered a +26% compounded annual return across a biotechnology mandate between 1995-2003. His experience also includes overseeing 14 Covered Call ETFs (over $0.7 Billion AUM) in Canada, the US & Australia while at Horizons Exchange Traded Funds.
Eden is a regular guest speaker on the biotech industry on Bloomberg TV, BNN, as well as an author and contributor to many industry sources and major press articles in the US and Canada. He also contributes as a speaker at numerous healthcare conferences.
Associate Portfolio Manager
Michael Bird is the Associate Portfolio Manager and Trader for the Next Edge Biotech and Life Sciences Opportunities Fund. He possesses over twenty-five years of equity, options and derivative trading experience. Previously he was Vice President and Head of the equity derivatives group at Desjardins Securities. Other prior experience includes Vice President and Senior Trader in the equity derivatives group at RBC, Vice President at CIBC Wood Gundy, and options and proprietary trader at BNS. Mike has served on the TSE Derivative Markets Committee and is a former Director and Chair of the Audit Committee of Intrinsyc Technologies Corporation (TSX: ITC) in addition to other board experience.